Evidence map›Paper›PMID 12854972›Full record

ArticleBMC medical genetics2003

Lamin A/C truncation in dilated cardiomyopathy with conduction disease.

Heather M MacLeod, Mary R Culley, Jill M Huber, Elizabeth M McNally

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00138931 (Genetic Studies of Patients and Their Families With Inherited Cardiovascular and Neuromuscular Diseases.), which is not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00138931 recruitingnot on this map

Genetic Studies of Patients and Their Families With Inherited Cardiovascular and Neuromuscular Diseases.

TypeobservationalSponsorUniversity of ChicagoRan1996 to 2030Enrolled2,000ConditionsCardiomyopathy, Arrhythmia, Muscular DystrophyArmsBlood draw (genetic testing)
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Epigenetics inCells · 2023
    Review
  4. Epigenetic reprogramming to prevent genetic cardiomyopathy.The Journal of clinical investigation · 2021
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Sudden cardiac death in a patient with lamin A/C mutation in the absence of dilated cardiomyopathy or conduction disease.Clinical research in cardiology : official journal of the German Cardiac Society · 2011
    Article
  12. Update 2011: clinical and genetic issues in familial dilated cardiomyopathy.Journal of the American College of Cardiology · 2011
    Review
  13. Article
  14. Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals.Genetics in medicine : official journal of the American College of Medical Genetics · 2010
    Article
  15. Review
  16. Identification of a new lamin A/C mutation in a Chinese family affected with atrioventricular block as the prominent phenotype.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2010
    Article
  17. Diseases of the nuclear envelope.Cold Spring Harbor perspectives in biology · 2010
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Heather M MacLeodSection of Cardiology, Department of Medicine, University of Chicago, Chicago, IL, USA. hmacleod@medicine.bsd.uchicago.edu
Mary R Culley
Jill M Huber
Elizabeth M McNally
University of Chicago · US

Funding

GENETICS STUDIES OF FAMILIAL DILATED CARDIOMYOPATHYR01HL063783 · NHLBI · UNIVERSITY OF CHICAGO · PI MCNALLY, ELIZABETH M · 2000 to 2003
$947k
NHLBI NIH HHS HL63783NHLBI NIH HHS R01 HL063783
6 · The paper itself

Abstract

backgroundMutations in the gene encoding the nuclear membrane protein lamin A/C have been associated with at least 7 distinct diseases including autosomal dominant dilated cardiomyopathy with conduction system disease, autosomal dominant and recessive Emery Dreifuss Muscular Dystrophy, limb girdle muscular dystrophy type 1B, autosomal recessive type 2 Charcot Marie Tooth, mandibuloacral dysplasia, familial partial lipodystrophy and Hutchinson-Gilford progeria.

methodsWe used mutation detection to evaluate the lamin A/C gene in a 45 year-old woman with familial dilated cardiomyopathy and conduction system disease whose family has been well characterized for this phenotype 1.

resultsDNA from the proband was analyzed, and a novel 2 base-pair deletion c.908_909delCT in LMNA was identified.

conclusionsMutations in the gene encoding lamin A/C can lead to significant cardiac conduction system disease that can be successfully treated with pacemakers and/or defibrillators. Genetic screening can help assess risk for arrhythmia and need for device implantation.

Indexed as

Alternative SplicingAmino Acid SequenceCardiomyopathy, DilatedFrameshift MutationGenotypeHumansLamin Type AMaleMiddle AgedMolecular Sequence DataPedigreePhenotypeSequence DeletionSick Sinus Syndromelamin CLamin Type A

Identifiers

PMID12854972
PMCPMC169171
OpenAlexW1653913370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.